SCHEMBL22889281

SCHEMBL22889281

c1ccc(-c2cc3ccccc3c3ccccc23)c(-c2cc(-c3cccc4c3oc3ccccc34)nc(-c3ccc(-c4cc5ccccc5c5ccccc45)cc3)n2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.45
ALDH1A1 P00352 4/20 0.36
HSD17B10 Q99714 3/20 0.36
HPGD P15428 3/20 0.36
TSHR P16473 3/20 0.36
MAPK1 P28482 2/20 0.36
CASP1 P29466 1/20 0.36
HIF1A Q16665 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PRKDC P78527 5/20 0.35
PIK3CD O00329 1/20 0.35
PIK3CB P42338 1/20 0.35
CYP11B1 P15538 1/20 0.35
GGPS1 O95749 1/20 0.35
MAPT P10636 5/20 0.34
KDM4E B2RXH2 3/20 0.34
POLB P06746 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
PTGES2 Q9H7Z7 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22889276 0.94 ALOX5 (0.44) ALOX5ALDH1A1HSD17B10HPGDTSHR
SCHEMBL22889154 0.94 ALOX5 (0.44) ALOX5ALDH1A1HSD17B10HPGDTSHR
SCHEMBL22888920 0.94 ALOX5 (0.44) ALOX5ALDH1A1HSD17B10HPGDTSHR
SCHEMBL22888938 0.94 ALOX5 (0.46) ALOX5ALDH1A1HSD17B10HPGDTSHR
SCHEMBL22888942 0.92 ALOX5 (0.44) ALOX5ALDH1A1HSD17B10HPGDTSHR
SCHEMBL22888930 0.91 ALOX5 (0.43) ALOX5ALDH1A1HSD17B10HPGDTSHR
SCHEMBL22888680 0.91 ALOX5 (0.43) ALOX5ALDH1A1HSD17B10HPGDTSHR
SCHEMBL22889320 0.90 ALOX5 (0.47) ALOX5ALDH1A1HSD17B10HPGDTSHR
SCHEMBL21304722 0.90 ALOX5 (0.44) ALOX5ALDH1A1HSD17B10HPGDTSHR
SCHEMBL22888895 0.89 ALOX5 (0.41) ALOX5ALDH1A1HSD17B10HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, RPS4Y1, AR ALOX5 3163/4885ALDH1A1 1387/4885HSD17B10 2902/4885
US-11765972-B2 Compound and organic electroluminescence device using the same AR, OR10J3, RPS4Y1 ALOX5 3071/4885ALDH1A1 1441/4885HSD17B10 2896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.